Skip to main content

Lupus

      Lupus GPT - a chatbot which is much more relevant to Lupus - for patients and physician question etc. #EULAR2024 - Will
      6 months 1 week ago
      Lupus GPT - a chatbot which is much more relevant to Lupus - for patients and physician question etc. #EULAR2024 - Will be functional soon. Looking forward to playing with this. #LLMs #ChatGPT More to come. @RheumNow https://t.co/mGXG6A85Hx
      Biomarkers in Lupus - Urine biomarkers @andreafava in #EULAR2024
      We need these biomarkers to come in mainstream clinical
      6 months 1 week ago
      Biomarkers in Lupus - Urine biomarkers @andreafava in #EULAR2024 We need these biomarkers to come in mainstream clinical practice if they work better than proteinuria. @RheumNow https://t.co/i7aeBx6qRR
      @Lupusreference noted data suggests pulse IV methylprednisolone yields better outcomes for LN than adjustments of chroni
      6 months 1 week ago
      @Lupusreference noted data suggests pulse IV methylprednisolone yields better outcomes for LN than adjustments of chronic oral steroids. #EULAR24 @RheumNow https://t.co/n93x036uIn
      Precision medicine in Lupus is far from reality today. @Lupusreference @RheumNow #EULAR2024
      6 months 1 week ago
      Precision medicine in Lupus is far from reality today. @Lupusreference @RheumNow #EULAR2024
      Whats new in Lupus #EULAR2024 @Lupusreference lecture - many pearls.
      Corticosteroids IV may be the way to go - referenc
      6 months 1 week ago
      Whats new in Lupus #EULAR2024 @Lupusreference lecture - many pearls. Corticosteroids IV may be the way to go - referencing @AliDuarteMD team (better outcomes compared to oral steroids) @RheumNow https://t.co/Fz1dZUVomF
      Should we treat to target (T2T) for #SLE or just do SOC and gestalt (as most do in clinical practice)? @Lupusreference #
      6 months 1 week ago
      Should we treat to target (T2T) for #SLE or just do SOC and gestalt (as most do in clinical practice)? @Lupusreference #EULAR24 @RheumNow
      Dr. G Schett reported using CAR-T cell Rx in patients w/ 1. pedi-SLE 2. CNS lupus 3. refractory cases with success. Pos
      6 months 1 week ago
      Dr. G Schett reported using CAR-T cell Rx in patients w/ 1. pedi-SLE 2. CNS lupus 3. refractory cases with success. Post- Rx vaccine response is fine, infection risk is less since pts no longer need steroids. He is still following the pts for relapse and AEs @RheumNow #EULAR24
      Pt with LN, endocarditis, pericarditis, arthritis, rash failed CTX, MMF, BEL, and SOC. She is 1000 days post CAR-T cell.
      6 months 1 week ago
      Pt with LN, endocarditis, pericarditis, arthritis, rash failed CTX, MMF, BEL, and SOC. She is 1000 days post CAR-T cell. Off immunomodulating drugs. #SLE in remission clinically and serologically. - Dr G Schett #EULAR24 @RheumNow https://t.co/3vdMtO6VWI
      🌎 Global disparities in steroid prescribing in #SLE

      πŸ’Š HCQ assoc with decreased steroid use

      πŸ“ˆ Other contributi
      6 months 1 week ago
      🌎 Global disparities in steroid prescribing in #SLE πŸ’Š HCQ assoc with decreased steroid use πŸ“ˆ Other contributing factors may be prevalence, severity & phenotype of disease, plus access to DMARDs & biologics πŸ“SLE poster tour 15:30 TODAY #EULAR2024 Abs #POS0013 @RheumNow https://t.co/7pL8kpeqOs
      ×